Strong Uptake For Incyte Eczema Cream Despite Formulation Issue
Physicians Keen On Topical Therapy
Ahead of pending regulatory decisions on both sides of the Atlantic for Opzelura, Incyte has reported promising progress for the JAK inhibitor in the highly competitive atopic dermatitis market.
